Clinical Trial Update: Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study [Phase 2]

View source ↗

Summary

This document notes a Phase 2 clinical trial (SHIFT Study) evaluating semaglutide for methamphetamine use disorder, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Kirby Institute | Conditions: Methamphetamine Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING